Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Interim data from phase I trial of Cortiject in diabetic macular edema disclosed at ISOPT

Dec. 21, 2009

PRO-131921 shows clinical activity in rituximab-relapsed/refractory indolent NHL patients

Dec. 18, 2009

Phase II data of cediranib plus fulvestrant in metastatic breast cancer disclosed

Dec. 18, 2009

FOV-2304 prevents retinal edema and inflammation in rat model of diabetic retinopathy

Dec. 18, 2009

Vorinostat in combination with tamoxifen safe and effective in phase II breast cancer trial

Dec. 17, 2009

Pilot trial data indicate beneficial effects of Copaxone in dry AMD

Dec. 17, 2009

Clinical data on candesartan in diabetic retinopathy disclosed at ISOPT

Dec. 17, 2009

Preliminary phase I safety and efficacy of IMGN-901 seen in pretreated MM patients

Dec. 17, 2009

Romiplostim safe and effective in phase I/II study in pediatric ITP patients

Dec. 17, 2009

Final data reported from phase Ib trial of atacicept in pretreated CLL patients

Dec. 17, 2009

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...